Effects of mutation and expression of PTEN gene mRNA on tumorigenesis and progression of epithelial ovarian cancer

Chinese Medical Sciences Journal

Volumn 19, Issue 1, 2004, Pages 25-30

  Chen, Ying ^b   Zheng, Huachuan ^a   Yang, Xuefei ^a   Sun, Limei ^b   Xin, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Shenyang Gynecology and Obstetrics Hospital   (China)

Author keywords

Gene expression; Mutation; Ovarian neoplasms; PTEN gene

Indexed keywords

MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENDOMETRIOID CARCINOMA; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; OVARY; OVARY CANCER; OVARY CARCINOMA; OVARY CYST; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CARCINOMA, ENDOMETRIOID; DOWN-REGULATION; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PHOSPHORIC MONOESTER HYDROLASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 1842760534     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-62.
2. Gu J, Tamura M, Yamada KM. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 1998;143:1375-83.
3. Tamura M, Gu J, Takino T, et al. Tumor suppressor PTEN inhibition of cell invasion, migration and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res 1999;59:442-9.
4. Tamura M, Gu J, Tran H, et al. PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 1999;91:1820-8.
5. Cantley LC, Neel BG. New insight into tumor suppression: PTEN suppresses tumor formation by restraining the ph-osphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999;96:4240-5.
6. Koul D, Parthasarathy R, Shen R, et al. Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 2001; 20:6669-78.
7. Huang J, Kontos CD. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem 2002;277:10760-6.
8. Birck A, Ahrenkiel V, Zeuthern J, et al. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies. J Invest Dermatol 2000;114: 277-80.
9. Tashiro H, Blazes MS, Wu R, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997;57: 3935-40.
10. Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64-7.
11. Whang YE, Wu X, Sawyers CL. Identification of a pseudogene that can masquerade as a mutant allele of the PTEN/MMAC1 tumor suppressor gene. J Natl Cancer Inst 1998;90:859-61.
12. Barnes MN, Grizzle WE, Grubbs CJ, et al. Paradigms for primary prevention of ovarian carcinoma. CA Cancer J Clin 2002;52:216-25.
13. Kondo K, Yao M, Kobayashi K, et al. PTEN/MMAC1/ TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines. Int J Cancer 2001;91:219-24.
14. Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002;70:829-44.
15. Wang DS, Rieger-Christ K, Latini JM, et al. Molecular analysis of PTEN and MXI1 in primary bladder carcinoma. Int J Cancer 2000;88:620-5.
16. Salvesen HB, MacDonald N, Ryan A, et al. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer 2001;91:22-6.
17. Aikawa R, Nagai T, Kudoh S, et al. Integrins play a critical role in mechanical stress-induced p38 MAPK activation. Hypertension 2002;39:233-8.
18. Yuan XJ, Whang YE. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene 2002; 21:319-27.
19. Schwartzbauer G, Robbins J. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J Biol Chem 2001;276:35786-93.
20. Carson JP, Kulik G, Weber MJ. Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3′-kinase and Akt/protein kinase B. Cancer Res 1999;59:1449-53.
21. Besson A, Yong VW. Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas. J Neurooncol 2001;51:245-64.